Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cromoglycate and related antiallergenic adverse reaction |
Causative agent (attribute) |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Nedocromil adverse reaction |
Causative agent (attribute) |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate adverse reaction |
Causative agent (attribute) |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Ketotifen adverse reaction |
Causative agent (attribute) |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Lodoxamide adverse reaction |
Causative agent (attribute) |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate allergy |
Causative agent (attribute) |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Product containing precisely cromoglicate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate 20mg inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate 20mg/2mL nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate 5mg inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate 5mg inhaler+spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate 5mg breath-actuated aerosol inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate compounds |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler+spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate+isoprenaline sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Product containing cromoglicate sodium and salbutamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate 2% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Product containing sodium cromoglycate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Inhaled sodium cromoglycate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Product containing sodium cromoglycate in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 20mg/2 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 0.8mg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 20mg/amp solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 100mg/5mL gas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 5.2mg/spr solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 10mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 800mcg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 40mg/spr solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 8.1g spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 40mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 0.8mg/spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Ophthalmic cromolyn sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Product containing cromolyn sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate+xylometazoline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromolyn sodium 100mg/5ml oral concentrate solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Cromoglicic acid-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
|
Sodium cromoglycate allergy |
Causative agent (attribute) |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
2 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
2 |
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Sodium cromoglycate 2% conventional release eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Sodium cromoglycate 2% conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Cromolyn sodium 5 mg/actuation pressurized suspension for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Cromolyn sodium 5 mg/actuation pressurized suspension for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Sodium cromoglicate 800 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Sodium cromoglicate 800 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Sodium cromoglicate 10 mg/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Sodium cromoglicate 10 mg/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Sodium cromoglicate 5 mg/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Sodium cromoglicate 5 mg/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Sodium cromoglicate 20 mg/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Sodium cromoglicate 20 mg/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium cromoglicate |
Inferred relationship |
Some |
1 |